Leerink Partnrs Has Positive Forecast for TENX Q2 Earnings
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Analysts at Leerink Partnrs boosted their Q2 2025 EPS estimates for Tenax Therapeutics in a report released on Thursday, May 15th. Leerink Partnrs analyst D. Risinger now expects that the specialty pharmaceutical company will post earnings of ($1.07) per share for the quarter, up from their previous […]
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Analysts at Leerink Partnrs boosted their Q2 2025 EPS estimates for Tenax Therapeutics in a report released on Thursday, May 15th. Leerink Partnrs analyst D. Risinger now expects that the specialty pharmaceutical company will post earnings of ($1.07) per share for the quarter, up from their previous […]
